Orthofix Medical Stock Fundamentals

OFIX Stock  USD 16.06  0.10  0.62%   
Orthofix Medical fundamentals help investors to digest information that contributes to Orthofix Medical's financial success or failures. It also enables traders to predict the movement of Orthofix Stock. The fundamental analysis module provides a way to measure Orthofix Medical's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Orthofix Medical stock.
Total Stockholder EquityProperty Plant And Equipment Net
At this time, Orthofix Medical's Extraordinary Items is fairly stable compared to the past year.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Orthofix Medical Company Return On Equity Analysis

Orthofix Medical's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.

Return On Equity

 = 

Net Income

Total Equity

More About Return On Equity | All Equity Analysis

Current Orthofix Medical Return On Equity

    
  -0.23  
Most of Orthofix Medical's fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Orthofix Medical is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
Competition

Orthofix Total Stockholder Equity

Total Stockholder Equity

277.87 Million

At this time, Orthofix Medical's Total Stockholder Equity is fairly stable compared to the past year.
Based on the latest financial disclosure, Orthofix Medical has a Return On Equity of -0.2287. This is 99.05% lower than that of the Health Care Equipment & Supplies sector and 97.38% lower than that of the Health Care industry. The return on equity for all United States stocks is 26.23% lower than that of the firm.

Orthofix Medical Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Orthofix Medical's current stock value. Our valuation model uses many indicators to compare Orthofix Medical value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Orthofix Medical competition to find correlations between indicators driving Orthofix Medical's intrinsic value. More Info.
JavaScript chart by amCharts 3.21.15IRMDCNMDITGRBRKRLIVNNUVAOFIX -0.0500.050.100.15 -0.2-0.100.10.20.3
Orthofix Medical is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . At this time, Orthofix Medical's Return On Equity is fairly stable compared to the past year. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Orthofix Medical's earnings, one of the primary drivers of an investment's value.

Orthofix Medical's Earnings Breakdown by Geography

Orthofix Return On Equity Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Orthofix Medical's direct or indirect competition against its Return On Equity to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Orthofix Medical could also be used in its relative valuation, which is a method of valuing Orthofix Medical by comparing valuation metrics of similar companies.
-0.22870.24310.14740.07720.0705100%
Orthofix Medical is currently under evaluation in return on equity category among its peers.

Orthofix Medical Current Valuation Drivers

We derive many important indicators used in calculating different scores of Orthofix Medical from analyzing Orthofix Medical's financial statements. These drivers represent accounts that assess Orthofix Medical's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Orthofix Medical's important valuation drivers and their relationship over time.
202020212022202320242025 (projected)
Market Cap828.1M612.2M411.7M495.1M665.8M430.0M
Enterprise Value756.8M546.8M380.9M591.6M762.2M447.2M

Orthofix Medical ESG Sustainability

Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Orthofix Medical's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Orthofix Medical's managers, analysts, and investors.
52.6%
Environmental
Governance
Social

Orthofix Fundamentals

Return On Equity-0.23
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31-200%-150%-100%-50%
Return On Asset-0.045
Profit Margin(0.16) %
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31-150%-100%-50%
Operating Margin(0.04) %
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31-150%-100%-50%
Current Valuation726.99 M
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31200%400%600%800%1,000%
Shares Outstanding39.02 M
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-3150%100%150%200%250%300%350%
Shares Owned By Insiders5.30 %
Shares Owned By Institutions86.55 %
Number Of Shares Shorted654.34 K
Price To Earning338.00 X
Price To Book1.25 X
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31-70%-60%-50%-40%-30%-20%-10%
Price To Sales0.79 X
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31-80%-60%-40%-20%
Revenue799.49 M
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-311,000%2,000%3,000%4,000%
Gross Profit558.07 M
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31500%1,000%1,500%2,000%2,500%
EBITDA(18.24 M)
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31-400%-200%0%200%400%
Net Income(126 M)
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31-3,000%-2,000%-1,000%0%1,000%
Cash And Equivalents59.54 M
Cash Per Share2.98 X
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-310%50%100%150%200%
Total Debt179.63 M
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-311,000%2,000%3,000%4,000%5,000%6,000%7,000%
Debt To Equity0.08 %
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-310%100%200%300%400%500%
Current Ratio3.15 X
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31-50%-40%-30%-20%-10%0%10%
Book Value Per Share13.07 X
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31100%200%300%400%500%600%
Cash Flow From Operations25.79 M
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31-1,000%0%1,000%2,000%
Short Ratio2.68 X
Earnings Per Share(3.27) X
Price To Earnings To Growth0.33 X
Target Price24.3
Number Of Employees1.62 K
Beta1.06
Market Capitalization635.48 M
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31200%400%600%800%
Total Asset893.29 M
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31500%1,000%1,500%2,000%2,500%
Retained Earnings(276.14 M)
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31-4,000%-2,000%0%2,000%
Working Capital264.66 M
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31
Current Asset147.87 M
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31200%400%600%800%1,000%1,200%1,400%
Current Liabilities52.94 M
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31500%1,000%1,500%2,000%2,500%
Net Asset893.29 M

About Orthofix Medical Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Orthofix Medical's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Orthofix Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Orthofix Medical based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Current Deferred Revenue(1.15)(1.09)
Total Revenue799.5 M839.5 M
Cost Of Revenue253.6 M266.3 M
Stock Based Compensation To Revenue 0.04  0.02 
Sales General And Administrative To Revenue 0.22  0.25 
Research And Ddevelopement To Revenue 0.09  0.05 
Capex To Revenue 0.04  0.04 
Revenue Per Share 20.97  14.27 
Ebit Per Revenue(0.11)(0.10)

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Orthofix Stock Analysis

When running Orthofix Medical's price analysis, check to measure Orthofix Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Orthofix Medical is operating at the current time. Most of Orthofix Medical's value examination focuses on studying past and present price action to predict the probability of Orthofix Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Orthofix Medical's price. Additionally, you may evaluate how the addition of Orthofix Medical to your portfolios can decrease your overall portfolio volatility.